Skip to content

A study on Pramaana Shareera which means bodily measurements with special reference to evaluate the relationship between Vishama Ayama Vistara equal arm span and height and prognosis of chronic liver disease

A study on Pramaana Shareera with special reference to evaluate the relationship between Vishama Ayama-Vistara and prognosis of chronic liver disease - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/101053
Enrollment
30
Registered
2026-01-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

Intervention1: Nil: Nil

Sponsors

J S Ayurveda Mahavidyalaya
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients already diagnosed with chronic liver disease having a bad prognosis those who are having model for end stage liver disease MELD score greater than 20 2 Individuals of either sex aged between 25 to 60 years

Exclusion criteria

Exclusion criteria: 1 Individuals with a history of fracture of a long bone. 2 Individuals who have undergone amputation of a limb. 3 Individuals with a deformity in the vertebral column. 4 Individual with congenital and acquired abnormalities of upper and lower limb.

Design outcomes

Primary

MeasureTime frame
The proposed research will help us to develop a prognostic tool i.e. the Vishama Ayama Vistara as an early indicator of bad prognosis of the CLD. This will assist physicians in predicting the possible bad prognosis at a very early stage of chronic liver disease by measuring the Ayama-Vistara of the patient.Timepoint: The proposed research will help us to develop a prognostic tool i.e. the Vishama Ayama Vistara as an early indicator of bad prognosis of the CLD. This will assist physicians in predicting the possible bad prognosis at a very early stage of chronic liver disease by measuring the Ayama-Vistara of the patient.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr seetharama Mithanthaya

J S Ayurveda Mahavidhyalaya Medical College

drsitharam1@gmail.com9901732256

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026